Bax translocation from the cytosol to mitochondria culminates a key step by which this protein mediates cell death. Here, we identified two amino acids, L70 and D71, within the BH3 domain of Bax that play a critical role in regulating Bax's cytosolic vs mitochondrial distribution. Individual substitution of these amino acids with alanine resulted in Bax conformational change, oligomerization, localization to mitochondria and cell death. Further mutational analysis indicated that L70 interacts with T174, V177 and A178 of Bax's C-terminal hydrophobic segment, while the negative charge of D71 is required for maintaining Bax in its soluble monomeric state. In summary, we have identified a new regulatory site that controls Bax's subcellular distribution and activation.
Introduction
Apoptosis plays a key role in the development and cellular homeostasis of multicellular organisms (Thompson, 1995) . The Bcl-2 family proteins are important regulators of apoptotic pathways, comprising both pro-survival members, such as Bcl-2 and Bcl-X L , and pro-apoptotic members, such as Bax and Bak (Adams and Cory, 1998) .
Bax is widely expressed in tissues and is involved in cell death regulation under physiological and pathological conditions. Mutations in Bax were found in 20% of human hematopoietic malignancies and 50% of human colon adenocarcinomas with the microsatellite mutator phenotype (Rampino et al., 1997; Meijerink et al., 1998) . These mutations likely enable the tumor cells to be less susceptible to cell death.
In healthy cells, Bax is primarily a soluble protein, and it exists as an inactive, monomeric protein Youle, 1997, 1998) . Upon the induction of apoptosis, Bax undergoes a conformational change, and translocates to mitochondria Wolter et al., 1997; Gross et al., 1998) . Mitochondrial-bound Bax promotes the release of cytochrome c and is associated with the loss of mitochondrial membrane potential (Dc m ) (Manon et al., 1997; Finucane et al., 1999; Smaili et al., 2001) . Cytochrome c then activates caspases through the formation of apoptosomes . The caspases in turn lead to apoptosis.
Members of the Bcl-2 family contain homologous regions known as the Bcl-2 homology domains (BH1, BH2, BH3 and BH4). The pro-survival members such as Bcl-2 and Bcl-X L contain all four domains. Some proapoptotic members, such as Bax and Bak, have BH1-3 domains and a pseudo-BH4 domain. Other pro-apoptotic members, such as Bid and Bad, possess only the BH3 domain (Adams and Cory, 1998) . Mutational analyses indicated that the BH1 and BH2 domains of Bcl-2 and Bcl-X L are required for heterodimerization with Bax to antagonize Bax's pro-apoptotic activity (Yin et al., 1994) . The BH3 domain of Bax was shown to be essential for dimerization (both homo-and hetero-) and for its apoptosis-inducing ability (Zha et al., 1996) .
Many members of the Bcl-2 family have a hydrophobic segment at their C-terminal end. In the case of Bax, this C-terminal tail is important for anchoring Bax to membranes upon its translocation to mitochondria. Mutations of amino acids within this region either lead to the constitutive localization of Bax to mitochondria (S184V or DS184) or lead to the abrogation of Bax's ability to translocate to mitochondria (S184K) (Nechushtan et al., 1999) . Solution NMR structural analysis of Bax indicated that this C-terminal hydrophobic segment is sequestered within a hydrophobic cleft formed by a-helices 2, 3 and 4 (Suzuki et al., 2000) . The BH3 domain forms part of helix 2. It is believed that the exposure of this C-terminal segment may lead to the translocation of Bax to mitochondrial membranes. In addition to the exposure of the C-terminal tail, it has been shown that Bax translocation to mitochondria is associated with a conformational change at its N terminus (Hsu and Youle, 1998; Desagher et al., 1999; Nechushtan et al., 1999) . This conformational change could be detected by the monoclonal antibody 6A7.
Although it has been shown previously that the C-terminus of Bax is needed for membrane localization of Bax, it has not previously been shown whether other domains of Bax are involved in regulating this localization. In the present study, using a variety of molecular biological, cell biological and biochemical approaches, we have shown that specific amino acid residues within the BH3 domain of Bax are critical in regulating Bax's conformation, multimeric state, cytosolic vs mitochondrial distribution and induction of apoptosis.
Results
Leu70 and Asp71 residues are critical in regulating Bax subcellular distribution The BH3 domain (aa 63-72) of Bax has been shown to be an important domain for Bax homo-and heterodimerization with anti-apoptotic members of the Bcl-2 family (Zha et al., 1996) . In this study, we have demonstrated that the BH3 domain has additional functions in the regulation of Bax's cytosolic vs mitochondrial distribution. We mutagenized each individual amino acid within the BH3 domain of Bax to alanine (Table 1) and cloned the Bax mutants into the C3-EGFP vector as green fluorescent protein (GFP) fusion constructs. These constructs were then transfected into Cos-7 cells and the transfected cells were examined by fluorescence microscopy. As shown in Figure 1a , wild-type GFP-Bax displayed both diffuse cytosolic and punctate mitochondrial localization patterns, consistent with previous reports of transient expression of GFP-Bax in mammalian cells .
We first examined the three negatively charged residues (D68, E69 and D71) within the BH3 domain with alanines. We found that the D71A mutation alone caused the complete constitutive localization of Bax to mitochondria (Figure 1a ). In contrast, the replacement of D68 by alanine resulted in increased Bax localization to mitochondria, while E69A mutation behaved like the wild-type Bax (Figure 1b) . Similarly, the change of two positively charged residues (K64 and R65) to alanines did not affect the ratio of cytosolic vs mitochondrialbound Bax.
Among all the scanned mutations, we found that L70 is another critical residue that regulates Bax solubility. Substitution of L70 to alanine also resulted in the constitutive localization of Bax to mitochondria (Figure 1a ). In addition, we found that the I66A mutation, like the D68A mutation, resulted in only enhanced Bax localization to mitochondria. On the other hand, mutations such as L63A, G67A and S72A had little effect in altering the subcellular distribution of Bax (Figure 1a and b) . The expression levels of Bax wild-type and mutant proteins in the transfected cells are comparable ( Figure 1c ) and the transfection efficiencies of the various mutants are similar as determined by flow cytometry analysis (Supplementary Figure 11) .
We have also assayed for Bax location by subcellular fractionation. As shown in Figure 1d , the L70A or D71A Bax mutant was found primarily in the heavy membrane fraction with a trace amount in the light membrane fraction. However, wild-type Bax was found in the soluble protein and heavy membrane fractions, with a small amount in the light membrane fractions.
Mitochondrial-bound Bax L70A and D71A mutants expose an N-terminal epitope Bax exposes its N-terminal epitope when it translocates to mitochondria (Hsu and Youle, 1998; Nechushtan et al., 1999) . To determine whether or not the same conformational change occurs in Bax L70A and D71A mutants, we subjected transfected cells to immunofluorescence labeling with the 6A7 antibody. As shown in Figure 2 , in cells transfected with wild-type GFP-Bax, the 6A7 antibody recognized only the mitochondrialbound Bax and showed little or no labeling of the cytosolic Bax. But in all the cells expressing GFP-Bax L70A or D71A, the 6A7 antibody strongly labeled the mutant Bax.
Using immunoprecipitation, we also demonstrated that these mutations can cause the exposure of the Nterminal epitope in recombinant murine Bax. As shown in Figure 2b , the 6A7 antibody bound strongly to the two Bax mutants while showing little affinity to the wildtype Bax.
Mitochondrial localization of Bax BH3 mutants leads to cell death and is associated with the release of cytochrome c and the loss of Dc m Bax translocation to mitochondria leads to cell death and in the process causes the release of cytochrome c from mitochondria to the cytosol and is associated with the loss of Dc m (Manon et al., 1997; Rosse et al., 1998; Smaili et al., 2001) . To examine cell death-induced change in nuclear morphology, Cos-7 cells transfected with various GFP-Bax constructs were stained with the Hoechst dye. As shown in Figure 3a , cells that had GFP-Bax (whether wild type or mutant) localized to the cytosol displayed a normal nuclear morphology. On the other hand, cells that had GFP-Bax localized to mitochondria displayed a condensed or fragmented nuclear morphology. As for Bax L70A and D71A mutants, virtually all the transfected cells displayed condensed or fragmented nuclei. 
The subcellular localization of cytochrome c in transfected cells was detected by immunofluorescence labeling with an anti-cytochrome c antibody. As shown in Figure 3b , cytochrome c was located primarily in the mitochondria of cells that had GFP-Bax localized to the cytosol. On the other hand, cells that had GFP-Bax localized to mitochondria displayed a diffuse, cytosolic cytochrome c labeling pattern. Accordingly, in virtually all GFP-Bax L70A and D71A mutant-transfected cells, a cytosolic distribution of cytochrome c was observed (Figure 3b ).
To examine the Dc m of the transfected cells, we stained these cells with the Dc m -sensitive dye tetramethylrhodamine (TMRE). In wild-type GFP-Bax-transfected cells that had Bax localized to the cytosol, the mitochondria of these cells were stained brightly with TMRE, indicative of an intact Dc m (Figure 3c ). On the other hand, the TMRE fluorescence was greatly diminished in those cells that had GFP-Bax localized to mitochondria ( Figure 3c ). Accordingly, cells transfected with GFPBax L70A or D71A mutants that had Bax constitutively localized to mitochondria, a very weak or no TMRE staining was observed.
Bcl-X L binds to Bax L70A and D71A mutants, but does not inhibit their membrane association Previously, it has been shown that Bcl-X L could block Bax translocation to mitochondria by inhibiting the oligomerization of Bax (Mikhailov et al., 2001) . This raises an important question of whether Bcl-X L could block the mitochondrial localization of the Bax mutants. To carry out this study, we co-transfected Cos-7 cells with GFP-Bax constructs and pcDNA3-Bcl-X L . Bcl-X L completely or significantly attenuated the mitochondrial localization of transiently transfected GFP-Bax and most of the Bax mutants. These cells displayed mainly a cytosolic Bax localization pattern. To our surprise, Bcl-X L was unable to prevent the membrane localization of L70A and D71A Bax mutants (Figure 4a and b). In the presence of Bcl-X L , these mutants displayed prominent mitochondrial localization. Interestingly, the I66A and D68A mutants that displayed enhanced mitochondrial localization now showed only a cytosolic localization pattern.
We also studied the in vitro binding of wild-type Bax and its mutants to isolated mitochondria from mouse liver. We found that significantly more mutant Bax proteins were bound to mitochondria compared to the wild-type Bax protein (Figure 4c ). This result indicates that Bax L70A and D71A mutant proteins have significantly higher affinity for isolated mitochondria than the wild-type Bax. In addition, we found that in the presence of Bcl-X L , the binding of wild-type Bax was slightly decreased, while no significant decrease in the binding of Bax L70A and D71A mutant proteins to mitochondria was observed.
The finding that Bcl-X L cannot inhibit the membrane localization of L70A and D71A Bax mutants prompted us to examine whether Bcl-X L could still antagonize the mitochondrial dysfunctions associated with the expression of these proteins. We transfected Cos-7 cells with GFP-Bax constructs and pcDNA3-Bcl-X L and subjected the transfected cells to either cytochrome c antibody labeling or TMRE dye staining (Figure 5a and b). We found that for I66A and D68A Bax mutants, in which Bcl-X L was effective at blocking their localization to mitochondria, it was also effective at preventing the release of cytochrome c and the loss of Dc m . On the other hand, for L70A and D71A Bax mutants, Bcl-X L was unable to completely prevent the release of cytochrome c and the loss of Dc m . In addition to carrying out the co-transfection study, we examined the efficacy of Bcl-X L at blocking the release of cytochrome c by Bax mutants in isolated mitochondria (Figure 5c ). We found that L70A and D71A Bax mutant proteins were more effective at promoting cytochrome c release than the wild-type Bax. Interestingly, we found that pre-incubation of mitochondria with Bcl-X L could effectively block the release of cytochrome c by both wild-type and mutant Bax proteins.
We then examined whether these mutations alter the ability of Bcl-X L to bind to these proteins. A previous report using the yeast two hybrid select system has shown that L70A and D71A mutations reduced their interaction with Bcl-X L . In our study, we transfected Cos-7 cells with GFP-Bax constructs in the presence of pcDNA3-Bcl-X L and carried out an immunoprecipitation analysis with antiBax 1F6 antibody. To our surprise, we found that the interaction between Bax mutants (I66A, D68A, L70A and D71A) and Bcl-X L was comparable to that of wildtype Bax (Figure 6 ). A similar result was obtained using pcDNA3-Bax constructs transfected cells (Supplementary Figure 12 ). A major difference between our study and that carried out by Wang et al. (1998) is that their yeast two-hybrid study was performed with C-terminal hydrophobic segment truncated Bax and Bcl-X L , whereas we use full-length proteins.
L70A and D71A Bax mutant proteins exist as oligomers To determine whether mutations that affect Bax localization also influence Bax multimeric state, we fractionated recombinant murine Bax proteins over an HW-55F size exclusion column. Wild-type Bax appeared as a monomer with an apparent molecular weight of 25 kDa (Figure 7a ). In contrast, both L70A and D71A mutant proteins appeared as oligomers. On the other hand, I66A and D68A mutants exist in both monomeric and oligomeric states. To examine the stability of Bax mutant oligomers, we pooled the column fractions containing oligomeric Bax L70A and D71A proteins and refractionated them over the gel filtration column. As shown in Figure 7b , the Bax mutant proteins retained their oligomeric state and did not dissociate into monomers.
In order to determine whether Bcl-X L could alter the multimeric states of the Bax mutant proteins, we transfected Cos-7 cells with wild-type GFP-Bax and various Bax mutants either in the presence or absence of Bcl-X L . The transfected cells were then solubilized in Chaps and the solubilized samples were fractionated over a Superdex 200 size exclusion column. As shown in Figure 7c , wild-type Bax and Bax I66A and D68A mutants displayed both oligomeric and monomeric forms, with I66A and D68A mutants having proportionally more oligomeric species than the wild-type protein. Bax L70A and D71A mutants, on the other hand, exist predominantly as oligomers. Coexpression with Bcl-X L significantly inhibited the oligomerization of wild-type Bax and Bax I66A and D68A mutants and partially inhibited the oligomerization of Bax L70A and D71A mutants.
L70 interacts with residues from C-terminal hydrophobic segment
Based on the solution NMR structure of Bax (Suzuki et al., 2000) , L70 extends from the BH3 domain and interacts hydrophobically with residues T174, V177 and A178 of the C-terminal hydrophobic helix of Bax (Figure 8 ). This raises the possibility that L70 stabilizes the monomeric form of Bax by hydrophobic interaction with its C-terminal helix. To further understand the underlying mechanism, we made additional mutants of L70. We found that when L70 was replaced by glycine or lysine, 100% of the transfected cells had GFP-Bax distributed to mitochondria. Meanwhile, replacement of L70 by isoleucine led to three-quarters of the transfected cells having mitochondrial-bound Bax (Figure 9a ). This result suggests that the hydrophobic side chain of L70 is important for maintaining Bax cytosolic localization.
In addition, we generated three mutants T174L, V177L and A178L to determine if they will destabilize the interaction between the BH3 domain and the C-terminal helix. We found that these three mutants were highly bound to mitochondria. For the doublemutant V177L/A178L, all transfected cells had Bax localized to mitochondria (Figure 9b and c) .
The negative charge of D71 is essential for the cytosolic localization of Bax To determine the importance of the negative charge of D71, we substituted D71 with asparagine and found that this mutant constitutively localized to mitochondria (Figure 10a ). We therefore speculated that the mechanism of Bax activation by the D71A mutation might be related to the loss of the negatively charged group on its side chain. Accordingly, we found that D71E mutant behaved like the wild-type Bax.
Based on the NMR structure of Bax, R34 and K119 appear to be located in close proximity to D71. To identify possible interaction between D71 and these residues, we made R34A and K119A mutants, which would eliminate electrostatic interactions between them. We found that the R34A and K119A Bax single mutants and the R34A/K119A double mutant behaved very much like the wild-type Bax (Figure 10b and c) . Furthermore, we made an R34E mutant, which is expected to produce a charge repulsion between E34 and D71. Surprisingly, this mutant also had the same subcellular distribution as the wild-type Bax. These Figure 6 Bcl-X L displayed comparable affinity between wild-type (WT) Bax and Bax mutants. Cos-7 cells were co-transfected with C3-EGFP-Bax constructs and pcDNA3-Bcl-X L . The cell lysates were subjected to immunoprecipitated with antihuman Bax 1F6 antibody. The immunoprecipitated products (top), cell lysates (middle) and flowthroughs (bottom) were analysed by western blotting using the antihuman Bax 2D2 and anti-Bcl-X L 2H12 antibodies. Lanes a, wild-type Bax; b, I66A; c, D68A; d, L70A and e, D71A mutants. studies indicate that the negative charge of D71 is important for regulating Bax subcellular distribution, but the mechanism does not involve any ionic interaction with R34 or K119.
Discussion
Redistribution of Bax from the cytosol to mitochondria culminates a key step by which this protein promotes apoptosis. Currently, two regions of Bax have been shown as regulatory domains that determine the subcellular localization of this protein. The first is the C-terminal hydrophobic domain and the second is the N-terminal apoptosis regulating targeting (ART) domain. It was reported that deletion of 21 amino acid residues of its C-terminal hydrophobic segment prevented Bax's ability to translocate to mitochondria and abrogated its ability to promote cell death Nechushtan et al., 1999) . Bax's C-terminal segment is believed to hide within a hydrophobic pocket in healthy cells, and it becomes exposed during apoptosis. As for the role of Bax's N terminus in regulating the solubility of this protein, an N-terminal epitope of this protein has been shown to become exposed when Bax translocates to mitochondria. In addition, Goping et al. (1998) have shown that the first 19 amino acids of Bax, or the ART sequence, is important in regulating Bax localization. Deletion of this sequence will also result in the constitutive localization of Bax to mitochondria (Cartron et al., 2003) .
Currently, it has been suggested that Bax translocation could be initiated by either BH3-only Bcl-2 family proteins or by the sequestration of anti-apoptotic proteins (Eskes et al., 2000; Kuwana et al., 2005; Willis et al., 2005) . Pagliari et al. (2005) have shown that heat treatment alone could lead to a direct activation of Bax. Because the oligomeric Bax does not revert back to its monomeric, cytoplasmic form (Nechushtan et al., 2001) , it suggests that Bax oligomer is a lower energy structure. This is consistent with a wound spring model, in which the higher energy Bax monomer must overcome an energy barrier in order to convert into a lower energy multimeric form. It is possible that our mutations in the BH3 domain, and other mutations in the ART and C-terminals domains that activate Bax, destabilize the monomeric form of Bax so that it more easily converts into the lower energy oligomer.
Based on the NMR structure of Bax, one face of Bax's C-terminal a-helix is buried in a hydrophobic cleft, part of which is formed by the BH3 domain. This enables Bax to exist predominantly as a soluble protein in the absence of apoptosis induction. In our study, we have shown that substitution of L70 or D71 in the BH3 domain with alanine leads to Bax multimerization and its constitutive localization to mitochondria.
The propensity of Bax L70A and D71A mutations to constitutively localize to mitochondria may be attributed to the tendency of these proteins to form oligomers. A previous study has shown that enforced dimerization of Bax is associated with the translocation of Bax to mitochondria . In addition, it has been proposed that dimerization of Bax requires the disengagement of its C-terminal segment from the hydrophobic cleft to enable the exposure of the hydrophobic BH3 domain (Suzuki et al., 2000) . In our study, we have demonstrated that a change of a single amino acid, either L70 or D71, is sufficient to induce Bax oligomerization and constitutive localization to mitochondria. In an in vitro binding assay, we have shown that Bax L70A and D71A mutants have a higher affinity for mitochondria compared to the wild-type Bax. It is possible that this multimeric form of Bax has the C-terminal tail exposed to facilitate translocation to Figure 8 A ribbon representation of the structure of Bax. Critical residues L70 and D71 identified in this study and nearby residues are labeled and shown as sticks. Conserved Bcl-2 homology motifs are purple (BH1), red (BH2), green (BH3) and yellow (pseudo BH4). mitochondrial membranes. In addition, we found that the extent of Bax translocation to mitochondria appears to correlate to its propensity to oligomerize. We found that Bax I66A and D68A mutants, which showed a greater extent of localization to mitochondria compared to the wild-type Bax, but less than L70A and D71A mutants, exist in both monomeric and oligomeric forms.
Previously, it has been shown that pro-survival members can inactivate Bax through heterodimerization (Oltvai et al., 1993) . In our study, we found that while Bcl-X L could antagonize the insertion of wild-type Bax, it was unable to inhibit the mitochondrial localization of Bax L70A and D71A mutants in transient transfection and in in vitro Bax mitochondrial binding studies. Interestingly, we found that Bcl-X L was capable of blocking Bax L70A and D71A mutants-induced cytochrome c release in isolated mitochondria, but not in transfected cells, suggesting that additional factors may be involved in intact cells.
The inability of Bcl-X L to block Bax mutant localization to mitochondria appears not to be due to the absence of interaction between Bax mutants and Bcl-X L , as we have shown that the mutant Bax proteins could bind equally well to Bcl-X L as the wild-type Bax. This raises an interesting question of why Bcl-X L could not inhibit the mitochondrial insertion of mutant Bax in spite of its ability to bind these mutant Bax proteins. Mitochondrial bound Bax forms a large oligomeric complex by recruiting additional cytosolic Bax molecules (Nechushtan et al., 2001) . The pro-survival Bcl-2 members bind to Bax and prevent Bax oligomerization on mitochondrial outer membranes (Mikhailov et al., 2001) . This action in effect inhibits the recruitment of cytosolic Bax to mitochondria. Unlike the cytosolic wild-type Bax, which has its C-terminal hydrophobic segment sequestered, the L70A and D71A mutants likely have their C-terminal hydrophobic segment exposed. Thus, these mutant proteins are more lipophilic and so they can directly insert into mitochondrial membranes, bypassing the oligomerization recruitment step that is blocked by Bcl-X L . Consistent with this hypothesis is our finding that Bcl-X L could partially inhibit the oligomerization of Bax L70A and D71A mutants, but not their mitochondrial membrane localization.
To gain insights into how L70 and D71 mutations could result in a conformational change that leads to Bax localization to mitochondria, we examined the NMR structure of Bax. Leucine 70 is located in a hydrophobic pocket where it may contact the carbon atoms of T174, V177 and A178 of the C-terminal helix of Bax (Figure 8 ). We hypothesized that L70A mutation weakened the extent of this hydrophobic interaction and thereby allowing the C-terminal helix greater freedom to separate from the hydrophobic pocket formed by the BH3 domain. Consistently, when L70 was mutated into the very small amino acid glycine, the resulting Bax mutant was constitutively mitochondrial bound. Similarly, mutation of L70 to lysine, which introduced a positively charged side chain into the hydrophobic core that could destabilize the BH3 domain, also resulted in constitutive Bax localization to mitochondria. Finally, when L70 was mutated to isoleucine, which has a similarly large hydrophobic group but with a somewhat different shape, the resulting mutant had a phenotype intermediate of the wild-type and L70A mutant Bax.
Although a decrease in hydrophobic interaction can destabilize a structure, steric effects are normally much more energetic. To test how steric hindrance would affect the hydrophobic interaction between the BH3 domain and the C-terminal helix, we made three mutant forms of Bax, T174L, V177L and A178L. The increased size of the side chain is expected to block sterically the favorable positioning of C-terminal helix against the BH3 domain. As we predicted, each of these three mutants displayed enhanced mitochondrial localization. We have also attempted to compensate for the loss of the hydrophobic interaction in the Bax L70A mutant by making compensatory L70A/T174L, L70A/V177L and L70A/A178L mutations. However, none of these mutations restored the inactive phenotype to Bax (Zhou and Hsu, unpublished data). This is not unexpected. Second site mutations may introduce many new factors that can prevent compensation (Mateu and Fersht, 1999) . For example, the mutant side chain may lack the correct shape, may form unanticipated interactions, or may sterically clash with other residues. Even if a putative compensating mutant side chain fills in the hydrophobic pocket and complements the shape of the mutant alanine side chain, it would not restore full wild-type binding energy. Being smaller and less hydrophobic than the wild-type leucine side chain, an alanine at position 70 could at best restore only part of the binding energy (Bowie et al., 1991) .
Aspartic acid 71 extends into the solvent on the opposite side of the helix of the BH3 domain. This negative charge appears to be important as a change to asparagine resulted in constitutive Bax localization to mitochondria. In support of this hypothesis is that a change of D71 to glutamic acid did not significantly affect the localization of the mutant protein. Based on the NMR structure of Bax, only the side chains of R34 and K119 are close enough to the side chain of D71 to form favorable interactions. Either of these basic residues might stabilize the Bax monomer by hydrogen bonding and by charge interactions with the acidic side chain of D71. However, we found that both R34A and K119A mutants had a wild-type phenotype. Surprisingly, even the double mutant (R34A/K119A) had wildtype activity. These results suggest that even though the negative charge on D71 is important for its function, the mechanism by which the D71A mutation activates Bax is unrelated to the interaction between D71 and these basic residues. Furthermore, since D71 appears to be solvent exposed, the mechanism of this mutation is not obvious. Perhaps the mechanism by which the D71 mutation favors oligomerization of Bax has to do with oligomer stabilization rather than with monomer destabilization, or that the critical D71 interactions occur in a conformation that is different from that seen in the NMR structure. More studies may be warranted to uncover the role of the D71 residue.
In this report, we have identified L70 and D71 as critical residues within the BH3 domain of Bax that regulate its multimeric state, localization and activation. We have shown that the negative charge of D71 and the hydrophobic interaction between L70 and three amino acids of the C-terminal hydrophobic segment are critical in maintaining the soluble, monomeric state of Bax. It remains to be addressed whether apoptotic signals directly affect the conformation of the Bax's BH3 domain.
Materials and methods
Generation of GFP-Bax constructs C3-EGFP-tagged wild-type human Bax was used as the template for mutagenesis by the QuikChange II site-directed mutagenesis kit. Mutations were confirmed by DNA sequencing.
Cell culture and transient transfection Cos-7 cells were grown in Dulbecco's modified Eagle's medium, supplemented with 10% fetal bovine serum and 2 mM glutamine. Cells were incubated at 371C in the presence of 5% CO 2 . For transfection studies, cells were plated onto sixwell plates the night before at approximately 70% confluency. C3-EGFP wild-type Bax (0.5 mg) or its mutant constructs and 3 ml FuGENE 6 were used per well. In co-transfection studies, pcDNA3-Bcl-X L and C3-EGFP-Bax wild-type and mutant constructs were used at a ratio of 3:1. Pan-caspase inhibitor z-VAD-fmk was added at 6 h post-transfection. To verify the expression of various Bax constructs, cell lysates were analysed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blotting with an anti-Bax antibody.
Determination of the subcellular distribution of GFP-Bax and its mutants by fluorescence microscopy Cos-7 cells were transiently transfected with various GFP-Bax constructs for 16 h and then incubated with Mitotracker (20 ng/ml) for 1 h. The stained cells were visualized at room temperature with an Olympus IX-70 fluorescence microscope using the Olympus LCPIanFI Â 20 objective lens (numerical aperture 0.4) with a Â 1.5 intermediate magnification. Images were captured by an Optronics DEI-750D digital imaging camera using the Digital Camera Acquire acquisition software. Adobe Photoshop 7.0 was used for image processing. The percentages of GFP-Bax punctate cells were quantitated from four separate visual fields.
(Additional methods descriptions can be found in the Supplementary Information).
